Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026
Go back to Lineage Cell Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 6, 2026| (NYSE: LCTX) | Delayed: 1.07 -0.02 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $ | |||
| Open | $1.11 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $ | |||
| Volume | 385,189 | |||||
| (NYSE: LCTX) | Delayed: 1.07 -0.02 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $ | |||
| Open | $1.11 | 52 Week Low | $ | |||
| Day High | $1.12 | P/E | N/A | |||
| Day Low | $1.05 | EPS | $ | |||
| Volume | 385,189 | |||||

